378 related articles for article (PubMed ID: 18381567)
61. Indications for angiography subsequent to coronary artery bypass grafting.
Alter P; Vogt S; Herzum M; Irqsusi M; Rupp H; Maisch B; Moosdorf R
Am Heart J; 2005 Jun; 149(6):1082-90. PubMed ID: 15976792
[TBL] [Abstract][Full Text] [Related]
62. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
[TBL] [Abstract][Full Text] [Related]
63. Postoperative delirium and short-term cognitive dysfunction occur more frequently in patients undergoing valve surgery with or without coronary artery bypass graft surgery compared with coronary artery bypass graft surgery alone: results of a pilot study.
Hudetz JA; Iqbal Z; Gandhi SD; Patterson KM; Byrne AJ; Pagel PS
J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):811-6. PubMed ID: 20655248
[TBL] [Abstract][Full Text] [Related]
64. Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.
Mahaffey KW; Van de Werf F; Shernan SK; Granger CB; Verrier ED; Filloon TG; Todaro TG; Adams PX; Levy JH; Hasselblad V; Armstrong PW
Am Heart J; 2006 Aug; 152(2):291-6. PubMed ID: 16875911
[TBL] [Abstract][Full Text] [Related]
65. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials.
Smith PK; Shernan SK; Chen JC; Carrier M; Verrier ED; Adams PX; Todaro TG; Muhlbaier LH; Levy JH;
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):89-98. PubMed ID: 20880552
[TBL] [Abstract][Full Text] [Related]
66. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial.
Thielmann M; Kottenberg E; Kleinbongard P; Wendt D; Gedik N; Pasa S; Price V; Tsagakis K; Neuhäuser M; Peters J; Jakob H; Heusch G
Lancet; 2013 Aug; 382(9892):597-604. PubMed ID: 23953384
[TBL] [Abstract][Full Text] [Related]
67. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
[TBL] [Abstract][Full Text] [Related]
68. Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery.
Kertai MD; Li YJ; Li YW; Ji Y; Alexander J; Newman MF; Smith PK; Joseph D; Mathew JP; Podgoreanu MV;
BMJ Open; 2015 May; 5(5):e006920. PubMed ID: 25948407
[TBL] [Abstract][Full Text] [Related]
69. The acute cardioprotective effect of glucocorticoid in myocardial ischemia-reperfusion injury occurring during cardiopulmonary bypass.
Enc Y; Karaca P; Ayoglu U; Camur G; Kurc E; Cicek S
Heart Vessels; 2006 May; 21(3):152-6. PubMed ID: 16715189
[TBL] [Abstract][Full Text] [Related]
70. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial.
Klatte K; Chaitman BR; Theroux P; Gavard JA; Stocke K; Boyce S; Bartels C; Keller B; Jessel A;
J Am Coll Cardiol; 2001 Oct; 38(4):1070-7. PubMed ID: 11583884
[TBL] [Abstract][Full Text] [Related]
71. Early and late prognostic implications of coronary artery bypass timing after myocardial infarction.
Ngaage DL; Sogliani F; Tang A
Eur J Cardiothorac Surg; 2013 Mar; 43(3):549-54. PubMed ID: 22564806
[TBL] [Abstract][Full Text] [Related]
72. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
[TBL] [Abstract][Full Text] [Related]
73. Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial.
Na HR; Kwon OS; Kang JK; Kim YH; Lim JY
Trials; 2022 May; 23(1):430. PubMed ID: 35606883
[TBL] [Abstract][Full Text] [Related]
74. Micronized purified flavonoid fraction in pretreating CABG patients.
Sirlak M; Akar AR; Eryilmaz S; Cetinkanat EK; Ozcinar E; Kaya B; Elhan AH; Ozyurda U
Tex Heart Inst J; 2010; 37(2):172-7. PubMed ID: 20401289
[TBL] [Abstract][Full Text] [Related]
75. The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis.
Zhang N; Lei J; Liu Q; Huang W; Xiao H; Lei H
Cardiology; 2015; 131(2):86-96. PubMed ID: 25871315
[TBL] [Abstract][Full Text] [Related]
76. Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial.
Alam SR; Lewis SC; Zamvar V; Pessotto R; Dweck MR; Krishan A; Goodman K; Oatey K; Harkess R; Milne L; Thomas S; Mills NM; Moore C; Semple S; Wiedow O; Stirrat C; Mirsadraee S; Newby DE; Henriksen PA
Heart; 2015 Oct; 101(20):1639-45. PubMed ID: 26310261
[TBL] [Abstract][Full Text] [Related]
77. Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial.
Bilecen S; de Groot JA; Kalkman CJ; Spanjersberg AJ; Brandon Bravo Bruinsma GJ; Moons KG; Nierich AP
JAMA; 2017 Feb; 317(7):738-747. PubMed ID: 28241354
[TBL] [Abstract][Full Text] [Related]
78. Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery.
Shim JK; Yang SY; Yoo YC; Yoo KJ; Kwak YL
Br J Anaesth; 2013 Jan; 110(1):47-53. PubMed ID: 22986417
[TBL] [Abstract][Full Text] [Related]
79. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial.
Whitlock RP; Devereaux PJ; Teoh KH; Lamy A; Vincent J; Pogue J; Paparella D; Sessler DI; Karthikeyan G; Villar JC; Zuo Y; Avezum Á; Quantz M; Tagarakis GI; Shah PJ; Abbasi SH; Zheng H; Pettit S; Chrolavicius S; Yusuf S;
Lancet; 2015 Sep; 386(10000):1243-1253. PubMed ID: 26460660
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
